Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Her doctor was on board, so long as Hasan also agreed to start resistance training—something she had only done briefly in the ...

Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive data from a 12-week Phase 2a ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs ...

Gemma left some of her 2.2 million social media followers in awe when she mentioned she had partnered with Yazen, a company ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

If you've resolved to quit drinking for the month, a little technological assistance may be the key to sticking to your goal.

There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...